Isothermal Nucleic Acid Amplification Technology Market Size, Share, and Outlook, H2-2025 Report- By Product (Assays, Kits, & Reagents, Systems), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Str
Description
Isothermal Nucleic Acid Amplification Technology Market Outlook
The global Isothermal Nucleic Acid Amplification Technology Market Size is valued at $5.4 Billion in 2025 and is forecast to reach $11.8 Billion in 2032 at a CAGR of 11.8%.
The Isothermal Nucleic Acid Amplification Technology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Isothermal Nucleic Acid Amplification Technology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Assays, Kits, & Reagents, Systems), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA), Nucleic Acid Sequence-based Amplification (NASBA), Nicking Enzyme Amplification Reaction (NEAR), Single Primer Isothermal Amplification (SPIA), Others), By Application (Disease Diagnosis, Blood Screening, Others), By End-User (Hospitals, Reference Laboratories, Academic & Research Institutes, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Isothermal Nucleic Acid Amplification Technology Market Insights, 2025
The isothermal nucleic acid amplification technology (INAAT) market addresses the need for rapid, accurate, and cost-effective molecular diagnostics without the complexity of thermal cycling. This technology enables DNA and RNA amplification at a constant temperature, making it particularly valuable in point-of-care testing and resource-limited settings. INAAT methods, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), are widely used for infectious disease detection, including emerging pathogens. The market has experienced heightened interest due to global efforts in pandemic preparedness and decentralized testing. Portability, low power requirements, and minimal instrumentation are key drivers of adoption in field diagnostics, veterinary testing, and food safety applications. Innovations are focusing on integrating INAAT with microfluidics, lateral flow detection, and smartphone-based readouts for user-friendly diagnostics. Increasing investment from public health agencies and private diagnostic companies is accelerating commercialization of new platforms. Regulatory approvals for over-the-counter and home-use kits are expanding consumer access. With its adaptability and scalability, INAAT is set to remain a cornerstone of rapid molecular testing.
Five Trends Shaping the Global Isothermal Nucleic Acid Amplification Technology Market in 2025 and Beyond
The global Isothermal Nucleic Acid Amplification Technology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Isothermal Nucleic Acid Amplification Technology Industry?
The Isothermal Nucleic Acid Amplification Technology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Isothermal Nucleic Acid Amplification Technology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Isothermal Nucleic Acid Amplification Technology Market Segment Insights
The Isothermal Nucleic Acid Amplification Technology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Assays, Kits, & Reagents, Systems), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA), Nucleic Acid Sequence-based Amplification (NASBA), Nicking Enzyme Amplification Reaction (NEAR), Single Primer Isothermal Amplification (SPIA), Others), By Application (Disease Diagnosis, Blood Screening, Others), By End-User (Hospitals, Reference Laboratories, Academic & Research Institutes, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Isothermal Nucleic Acid Amplification Technology Industry Value Chain
The chapter identifies potential companies and their operations across the global Isothermal Nucleic Acid Amplification Technology Industry ecosystem. It assists decision-makers in evaluating global Isothermal Nucleic Acid Amplification Technology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Isothermal Nucleic Acid Amplification Technology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Isothermal Nucleic Acid Amplification Technology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Isothermal Nucleic Acid Amplification Technology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Isothermal Nucleic Acid Amplification Technology Market.
Europe Isothermal Nucleic Acid Amplification Technology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Isothermal Nucleic Acid Amplification Technology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Isothermal Nucleic Acid Amplification Technology Industry competitiveness. The report analyses the key Isothermal Nucleic Acid Amplification Technology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Isothermal Nucleic Acid Amplification Technology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Isothermal Nucleic Acid Amplification Technology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Isothermal Nucleic Acid Amplification Technology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Isothermal Nucleic Acid Amplification Technology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Isothermal Nucleic Acid Amplification Technology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Isothermal Nucleic Acid Amplification Technology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Atila Biosystems Inc, Becton, Dickinson and Company, bioMérieux SA, DiaSorin S.p.A., Eiken Chemical Co. Ltd, General Electric Company, Genomtec Sp. z o.o., GenoSensor Corp, Grifols S.A., Hologic Inc, Jena Bioscience GmbH, LGC Ltd, Life Sciences Advanced Technologies Inc, Mast Group Ltd, Meridian Bioscience Inc, New England Biolabs Inc, OptiGene Ltd, PCR Biosystems Ltd, QIAGEN N.V., Quidel Corp, Tecan Trading AG, Thermo Fisher Scientific Inc, TwistDx Ltd, Ustar Biotechnologies (Hangzhou) Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Isothermal Nucleic Acid Amplification Technology Market Scope
Leading Segments
By Product
Assays, Kits, & Reagents
Systems
By Technology
Transcription Mediated Amplification (TMA)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Helicase-dependent Amplification (HDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Nicking Enzyme Amplification Reaction (NEAR)
Single Primer Isothermal Amplification (SPIA)
Others
By Application
Disease Diagnosis
Blood Screening
Others
By End-User
Hospitals
Reference Laboratories
Academic & Research Institutes
Others
Leading Companies
Abbott Laboratories
Atila Biosystems Inc
Becton, Dickinson and Company
bioMérieux SA
DiaSorin S.p.A.
Eiken Chemical Co. Ltd
General Electric Company
Genomtec Sp. z o.o.
GenoSensor Corp
Grifols S.A.
Hologic Inc
Jena Bioscience GmbH
LGC Ltd
Life Sciences Advanced Technologies Inc
Mast Group Ltd
Meridian Bioscience Inc
New England Biolabs Inc
OptiGene Ltd
PCR Biosystems Ltd
QIAGEN N.V.
Quidel Corp
Tecan Trading AG
Thermo Fisher Scientific Inc
TwistDx Ltd
Ustar Biotechnologies (Hangzhou) Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Isothermal Nucleic Acid Amplification Technology Market Size is valued at $5.4 Billion in 2025 and is forecast to reach $11.8 Billion in 2032 at a CAGR of 11.8%.
The Isothermal Nucleic Acid Amplification Technology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Isothermal Nucleic Acid Amplification Technology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Assays, Kits, & Reagents, Systems), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA), Nucleic Acid Sequence-based Amplification (NASBA), Nicking Enzyme Amplification Reaction (NEAR), Single Primer Isothermal Amplification (SPIA), Others), By Application (Disease Diagnosis, Blood Screening, Others), By End-User (Hospitals, Reference Laboratories, Academic & Research Institutes, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Isothermal Nucleic Acid Amplification Technology Market Insights, 2025
The isothermal nucleic acid amplification technology (INAAT) market addresses the need for rapid, accurate, and cost-effective molecular diagnostics without the complexity of thermal cycling. This technology enables DNA and RNA amplification at a constant temperature, making it particularly valuable in point-of-care testing and resource-limited settings. INAAT methods, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), are widely used for infectious disease detection, including emerging pathogens. The market has experienced heightened interest due to global efforts in pandemic preparedness and decentralized testing. Portability, low power requirements, and minimal instrumentation are key drivers of adoption in field diagnostics, veterinary testing, and food safety applications. Innovations are focusing on integrating INAAT with microfluidics, lateral flow detection, and smartphone-based readouts for user-friendly diagnostics. Increasing investment from public health agencies and private diagnostic companies is accelerating commercialization of new platforms. Regulatory approvals for over-the-counter and home-use kits are expanding consumer access. With its adaptability and scalability, INAAT is set to remain a cornerstone of rapid molecular testing.
Five Trends Shaping the Global Isothermal Nucleic Acid Amplification Technology Market in 2025 and Beyond
The global Isothermal Nucleic Acid Amplification Technology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Isothermal Nucleic Acid Amplification Technology Industry?
The Isothermal Nucleic Acid Amplification Technology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Isothermal Nucleic Acid Amplification Technology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Isothermal Nucleic Acid Amplification Technology Market Segment Insights
The Isothermal Nucleic Acid Amplification Technology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Assays, Kits, & Reagents, Systems), By Technology (Transcription Mediated Amplification (TMA), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Helicase-dependent Amplification (HDA), Nucleic Acid Sequence-based Amplification (NASBA), Nicking Enzyme Amplification Reaction (NEAR), Single Primer Isothermal Amplification (SPIA), Others), By Application (Disease Diagnosis, Blood Screening, Others), By End-User (Hospitals, Reference Laboratories, Academic & Research Institutes, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Isothermal Nucleic Acid Amplification Technology Industry Value Chain
The chapter identifies potential companies and their operations across the global Isothermal Nucleic Acid Amplification Technology Industry ecosystem. It assists decision-makers in evaluating global Isothermal Nucleic Acid Amplification Technology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Isothermal Nucleic Acid Amplification Technology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Isothermal Nucleic Acid Amplification Technology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Isothermal Nucleic Acid Amplification Technology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Isothermal Nucleic Acid Amplification Technology Market.
Europe Isothermal Nucleic Acid Amplification Technology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Isothermal Nucleic Acid Amplification Technology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Isothermal Nucleic Acid Amplification Technology Industry competitiveness. The report analyses the key Isothermal Nucleic Acid Amplification Technology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Isothermal Nucleic Acid Amplification Technology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Isothermal Nucleic Acid Amplification Technology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Isothermal Nucleic Acid Amplification Technology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Isothermal Nucleic Acid Amplification Technology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Isothermal Nucleic Acid Amplification Technology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Isothermal Nucleic Acid Amplification Technology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Atila Biosystems Inc, Becton, Dickinson and Company, bioMérieux SA, DiaSorin S.p.A., Eiken Chemical Co. Ltd, General Electric Company, Genomtec Sp. z o.o., GenoSensor Corp, Grifols S.A., Hologic Inc, Jena Bioscience GmbH, LGC Ltd, Life Sciences Advanced Technologies Inc, Mast Group Ltd, Meridian Bioscience Inc, New England Biolabs Inc, OptiGene Ltd, PCR Biosystems Ltd, QIAGEN N.V., Quidel Corp, Tecan Trading AG, Thermo Fisher Scientific Inc, TwistDx Ltd, Ustar Biotechnologies (Hangzhou) Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Isothermal Nucleic Acid Amplification Technology Market Scope
Leading Segments
By Product
Assays, Kits, & Reagents
Systems
By Technology
Transcription Mediated Amplification (TMA)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Helicase-dependent Amplification (HDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Nicking Enzyme Amplification Reaction (NEAR)
Single Primer Isothermal Amplification (SPIA)
Others
By Application
Disease Diagnosis
Blood Screening
Others
By End-User
Hospitals
Reference Laboratories
Academic & Research Institutes
Others
Leading Companies
Abbott Laboratories
Atila Biosystems Inc
Becton, Dickinson and Company
bioMérieux SA
DiaSorin S.p.A.
Eiken Chemical Co. Ltd
General Electric Company
Genomtec Sp. z o.o.
GenoSensor Corp
Grifols S.A.
Hologic Inc
Jena Bioscience GmbH
LGC Ltd
Life Sciences Advanced Technologies Inc
Mast Group Ltd
Meridian Bioscience Inc
New England Biolabs Inc
OptiGene Ltd
PCR Biosystems Ltd
QIAGEN N.V.
Quidel Corp
Tecan Trading AG
Thermo Fisher Scientific Inc
TwistDx Ltd
Ustar Biotechnologies (Hangzhou) Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
198 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Isothermal Nucleic Acid Amplification Technology Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Isothermal Nucleic Acid Amplification Technology Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Isothermal Nucleic Acid Amplification Technology Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Isothermal Nucleic Acid Amplification Technology Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Isothermal Nucleic Acid Amplification Technology Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Assays, Kits, & Reagents
- Systems
- By Technology
- Transcription Mediated Amplification (TMA)
- Loop-mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Helicase-dependent Amplification (HDA)
- Nucleic Acid Sequence-based Amplification (NASBA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Single Primer Isothermal Amplification (SPIA)
- Others
- By Application
- Disease Diagnosis
- Blood Screening
- Others
- By End-User
- Hospitals
- Reference Laboratories
- Academic & Research Institutes
- Others
- 6. Global Isothermal Nucleic Acid Amplification Technology Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Isothermal Nucleic Acid Amplification Technology Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Isothermal Nucleic Acid Amplification Technology Market Trends and Growth Opportunities
- 6.2.1 North America Isothermal Nucleic Acid Amplification Technology Market Outlook by Type
- 6.2.2 North America Isothermal Nucleic Acid Amplification Technology Market Outlook by Application
- 6.3 North America Isothermal Nucleic Acid Amplification Technology Market Outlook by Country
- 6.3.1 The US Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 6.3.2 Canada Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 6.3.3 Mexico Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7. Europe Isothermal Nucleic Acid Amplification Technology Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Isothermal Nucleic Acid Amplification Technology Market Trends and Growth Opportunities
- 7.2.1 Europe Isothermal Nucleic Acid Amplification Technology Market Outlook by Type
- 7.2.2 Europe Isothermal Nucleic Acid Amplification Technology Market Outlook by Application
- 7.3 Europe Isothermal Nucleic Acid Amplification Technology Market Outlook by Country
- 7.3.2 Germany Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.3 France Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.4 The UK Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.5 Spain Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.6 Italy Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.7 Russia Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook by Type
- 8.2.2 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook by Application
- 8.3 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook by Country
- 8.3.1 China Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.2 India Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.3 Japan Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.4 South Korea Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.5 Australia Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.6 South East Asia Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 9. South America Isothermal Nucleic Acid Amplification Technology Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Isothermal Nucleic Acid Amplification Technology Market Trends and Growth Opportunities
- 9.2.1 South America Isothermal Nucleic Acid Amplification Technology Market Outlook by Type
- 9.2.2 South America Isothermal Nucleic Acid Amplification Technology Market Outlook by Application
- 9.3 South America Isothermal Nucleic Acid Amplification Technology Market Outlook by Country
- 9.3.1 Brazil Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 9.3.2 Argentina Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10. Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Outlook by Type
- 10.2.2 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Outlook by Application
- 10.3 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Outlook by Country
- 10.3.1 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10.3.2 The UAE Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10.3.4 South Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10.3.5 Egypt Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Atila Biosystems Inc
- Becton, Dickinson and Company
- bioMérieux SA
- DiaSorin S.p.A.
- Eiken Chemical Co. Ltd
- General Electric Company
- Genomtec Sp. z o.o.
- GenoSensor Corp
- Grifols S.A.
- Hologic Inc
- Jena Bioscience GmbH
- LGC Ltd
- Life Sciences Advanced Technologies Inc
- Mast Group Ltd
- Meridian Bioscience Inc
- New England Biolabs Inc
- OptiGene Ltd
- PCR Biosystems Ltd
- QIAGEN N.V.
- Quidel Corp
- Tecan Trading AG
- Thermo Fisher Scientific Inc
- TwistDx Ltd
- Ustar Biotechnologies (Hangzhou) Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
